Global Orally Disintegrating Tablet Market Status and Outlook 2018-2025

August 2018 | 130 pages | ID: G738A78A9A7EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Teva
• Merck
• Mylan
• Pfizer
• Johnson and Johnson
• GSK
• Otsuka
• Eli Lilly and Company
• AstraZeneca
• Bristol-Myers Squibb
• Conquer

Market by Type

• Anti-Psychotics Drug
• Anti-Epileptics Drug
• Others

Market by Application

• CNS Diseases
• Gastrointestinal Diseases
• CVS Diseases
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Orally Disintegrating Tablet Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Anti-Psychotics Drug
  3.1.2 Anti-Epileptics Drug
  3.1.3 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 CNS Diseases
  4.1.2 Gastrointestinal Diseases
  4.1.3 CVS Diseases
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Anti-Psychotics Drug Production by Region
    6.1.1.2 Anti-Epileptics Drug Production by Region
    6.1.1.3 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 CNS Diseases Production by Region
    6.1.2.2 Gastrointestinal Diseases Production by Region
    6.1.2.3 CVS Diseases Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Anti-Psychotics Drug Demand by Region
    6.2.1.2 Anti-Epileptics Drug Demand by Region
    6.2.1.3 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 CNS Diseases Demand by Region
    6.2.2.2 Gastrointestinal Diseases Demand by Region
    6.2.2.3 CVS Diseases Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Teva
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Mylan
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Johnson and Johnson
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 GSK
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Otsuka
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Eli Lilly and Company
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 AstraZeneca
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Bristol-Myers Squibb
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Conquer

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Orally Disintegrating Tablet Industry Dynamics & Regulations List
Table Global Orally Disintegrating Tablet Sales Revenue, Cost and Margin, 2015-2018E
Table Global Orally Disintegrating Tablet Market Status by Type 2015-2018E, in USD Million
Table Global Orally Disintegrating Tablet Market Status by Application 2015-2018E, in USD Million
Table Global Orally Disintegrating Tablet Market Status by Application 2015-2018E, in Volume
Table Global Orally Disintegrating Tablet Market by Region 2015-2018E, in USD Million
Table Global Orally Disintegrating Tablet Market Share by Region in 2018, in USD Million
Table Global Orally Disintegrating Tablet Market by Region 2015-2018E, in Volume
Table Global Orally Disintegrating Tablet Market Share by Region in 2018, in Volume
Table Anti-Psychotics Drug Production Value by Region 2015-2018E, in USD Million
Table Anti-Psychotics Drug Production Volume by Region 2015-2018E, in Volume
Table Anti-Epileptics Drug Production Value by Region 2015-2018E, in USD Million
Table Anti-Epileptics Drug Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table CNS Diseases Production Value by Region 2015-2018E, in USD Million
Table CNS Diseases Production Volume by Region 2015-2018E, in Volume
Table Gastrointestinal Diseases Production Value by Region 2015-2018E, in USD Million
Table Gastrointestinal Diseases Production Volume by Region 2015-2018E, in Volume
Table CVS Diseases Production Value by Region 2015-2018E, in USD Million
Table CVS Diseases Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Anti-Psychotics Drug Market Size by Region 2015-2018E, in USD Million
Table Anti-Psychotics Drug Market Size by Region 2015-2018E, in Volume
Table Anti-Epileptics Drug Market Size by Region 2015-2018E, in USD Million
Table Anti-Epileptics Drug Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table CNS Diseases Market Size by Region 2015-2018E, in USD Million
Table CNS Diseases Market Size by Region 2015-2018E, in Volume
Table Gastrointestinal Diseases Market Size by Region 2015-2018E, in USD Million
Table Gastrointestinal Diseases Market Size by Region 2015-2018E, in Volume
Table CVS Diseases Market Size by Region 2015-2018E, in USD Million
Table CVS Diseases Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalOrally Disintegrating Tablet Forecast by Type 2019F-2025F, in USD Million
Table Orally Disintegrating Tablet Forecast by Type 2019F-2025F, in Volume
Table Orally Disintegrating Tablet Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Orally Disintegrating Tablet Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Orally Disintegrating Tablet Market Forecast by Region 2019F-2025F, in USD Million
Table Orally Disintegrating Tablet Market Forecast by Region 2019F-2025F, in Volume
Table Teva Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Teva
Table Merck Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Merck
Table Mylan Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Mylan
Table Pfizer Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Pfizer
Table Johnson and Johnson Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Johnson and Johnson
Table GSK Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of GSK
Table Otsuka Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Otsuka
Table Eli Lilly and Company Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Eli Lilly and Company
Table AstraZeneca Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of AstraZeneca
Table Bristol-Myers Squibb Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Bristol-Myers Squibb
Table Conquer Information
Table Orally Disintegrating Tablet Sales, Cost, Margin of Conquer
Table Global Orally Disintegrating Tablet Sales Revenue by Company 2015-2017, in USD Million
Table Global Orally Disintegrating Tablet Sales Volume by Company 2015-2017, in Volume
Table Global Orally Disintegrating Tablet Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Orally Disintegrating Tablet Picture
Figure Orally Disintegrating Tablet Industry Chain Diagram
Figure Global Orally Disintegrating Tablet Sales Revenue 2015-2018E, in USD Million
Figure Global Orally Disintegrating Tablet Sales Volume 2015-2018E, in Volume
Figure Global Orally Disintegrating Tablet Market Status by Type 2015-2018E, in Volume
Figure North America Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure North America Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure Europe Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure Europe Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure South America Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure South America Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure Middle East Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure Africa Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in USD Million
Figure Africa Orally Disintegrating Tablet Market Size and Growth 2015-2018E, in Volume
Figure Global Orally Disintegrating Tablet Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Orally Disintegrating Tablet Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Orally Disintegrating Tablet Sales Price Forecast 2019F-2025F
Figure Global Orally Disintegrating Tablet Gross Margin Forecast 2019F-2025F
Figure Global Orally Disintegrating Tablet Sales Revenue by Company in 2018, in USD Million
Figure Global Orally Disintegrating Tablet Price by Company in 2018
Figure Global Orally Disintegrating Tablet Gross Margin by Company in 2018